More SEC Filings
View Older Stories View Newer Stories-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: CHUNG DANIEL C
-
Form 4 LITTELFUSE INC /DE For: Apr 28 Filed by: Chu Maggie
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Payne Tina M
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Brownhill Jean
-
Form 4 National Bank Holdings For: Apr 28 Filed by: Newfield Richard U Jr.
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Sahu Sushmita
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Martins Michael D.
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: BAIRD CHARLES F JR
-
Form 4 EverCommerce Inc. For: Apr 28 Filed by: Remer Eric Richard
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Crawford Ankur
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Pavone Sergio M.
-
Form 4 National Bank Holdings For: Apr 28 Filed by: Gooden Emily
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: ALGER HILARY M
-
Form 4 QUALCOMM INC/DE For: Apr 30 Filed by: Grech Patricia Y
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: ALGER ASSOCIATES INC
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Novo Holdings A/S
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: LIEBES HAL
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Nadel Jay C
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: RA Capital Nexus Fund II, L.P.
-
Form 4 STARBUCKS CORP For: Apr 29 Filed by: KELLY SARA
-
Form 3 Alger Next Gen Growth For: Apr 30 Filed by: Hine Christopher
-
Form 4 Expensify, Inc. For: Apr 28 Filed by: Alvarez Divo Carlos Eduardo
-
Form 4 Lucid Group, Inc. For: Apr 28 Filed by: PUBLIC INVESTMENT FUND
-
Form 3 AAON, INC. For: Apr 20 Filed by: Cheung Chung Kin
-
Form 4 Kiniksa Pharmaceuticals For: Apr 28 Filed by: Patel Sanj K
-
Form 4 Owlet, Inc. For: Oct 16 Filed by: Kim John C.
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: MARAGANORE JOHN
-
Form SCHEDULE 13G Pyrophyte Acquisition Filed by: Harraden Circle Investments, LLC
-
Form 4 CARLISLE COMPANIES INC For: Apr 29 Filed by: Collins Jonathan R.
-
Form SCHEDULE 13D/A Lucid Group, Inc. Filed by: Ayar Third Investment Co
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: RYAN PATRICK G JR
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Murthy Ananthram Sreenivasa
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: ROGERS JOHN W JR
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Bain Linda
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: OHALLERAN MICHAEL D
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Behrndt-Eriksen Mads Nikolaj
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Tadvalkar Laura
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: Kuczinski Anthony J
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: CORTEZI NICHOLAS DOMINIC
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Vaishnaw Akshay
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: Cornelli Francesca
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Madigan Catherine
-
Form 3 Hemab Therapeutics Holdi For: Apr 30 Filed by: Sorensen Benny
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: COLLINS MICHELLE L
-
Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: BUNGERT MICHAEL G
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: BOLGER DAVID P
-
Form 4 RYAN SPECIALTY HOLDINGS, For: Apr 28 Filed by: Bienen Henry S
-
Form 144 Kinetik Holdings Inc. Filed by: ISQ Global Fund II GP LLC
-
Form 4 Corteva, Inc. For: Apr 28 Filed by: EVERITT DAVID C


